“…This is underpinned by the fact that the short half-life of 99m Tc leaves little time for ne-adjustments of several synthesis parameters (e.g., the exact amount of 99m Tc/ 99 Tc eluting from the generator, pH, O 2 partial pressure, etc.). 9,13 Tc radiopharmaceuticals may contain species in various oxidation states, which can result in a loss of contrast in scintigraphy while exposing patients to unnecessary radiation. 14 The amount and identity of impurities are oen unknown and even slight effects and deviations during synthesis, storage and administration may lead to a signicant quality loss in scintigraphy.…”